5-Fluorouracil derivatives. IV. Synthesis of antitumor-active acyloxyalkyl-5-fluorouracils. 1984

S Ozaki, and Y Watanabe, and T Hoshiko, and H Mizuno, and K Ishikawa, and H Mori

UI MeSH Term Description Entries
D005472 Fluorouracil A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid. 5-FU,5-FU Lederle,5-FU Medac,5-Fluorouracil,5-Fluorouracil-Biosyn,5-HU Hexal,5FU,Adrucil,Carac,Efudex,Efudix,Fluoro-Uracile ICN,Fluoroplex,Fluorouracil Mononitrate,Fluorouracil Monopotassium Salt,Fluorouracil Monosodium Salt,Fluorouracil Potassium Salt,Fluorouracil-GRY,Fluorouracile Dakota,Fluorouracilo Ferrer Far,Fluoruracil,Fluracedyl,Flurodex,Haemato-FU,Neofluor,Onkofluor,Ribofluor,5 FU Lederle,5 FU Medac,5 Fluorouracil,5 Fluorouracil Biosyn,5 HU Hexal,Dakota, Fluorouracile,Fluoro Uracile ICN,Fluorouracil GRY,Haemato FU
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

S Ozaki, and Y Watanabe, and T Hoshiko, and H Mizuno, and K Ishikawa, and H Mori
August 1985, Chemical & pharmaceutical bulletin,
S Ozaki, and Y Watanabe, and T Hoshiko, and H Mizuno, and K Ishikawa, and H Mori
September 1987, Chemical & pharmaceutical bulletin,
S Ozaki, and Y Watanabe, and T Hoshiko, and H Mizuno, and K Ishikawa, and H Mori
January 1996, Medicinal research reviews,
S Ozaki, and Y Watanabe, and T Hoshiko, and H Mizuno, and K Ishikawa, and H Mori
May 1998, Yao xue xue bao = Acta pharmaceutica Sinica,
S Ozaki, and Y Watanabe, and T Hoshiko, and H Mizuno, and K Ishikawa, and H Mori
February 2003, Bioorganic & medicinal chemistry,
S Ozaki, and Y Watanabe, and T Hoshiko, and H Mizuno, and K Ishikawa, and H Mori
November 1990, Chemical & pharmaceutical bulletin,
S Ozaki, and Y Watanabe, and T Hoshiko, and H Mizuno, and K Ishikawa, and H Mori
August 2009, Molecules (Basel, Switzerland),
S Ozaki, and Y Watanabe, and T Hoshiko, and H Mizuno, and K Ishikawa, and H Mori
December 1979, Bollettino chimico farmaceutico,
S Ozaki, and Y Watanabe, and T Hoshiko, and H Mizuno, and K Ishikawa, and H Mori
August 2013, Journal of biomedical materials research. Part A,
S Ozaki, and Y Watanabe, and T Hoshiko, and H Mizuno, and K Ishikawa, and H Mori
October 1987, Chemical & pharmaceutical bulletin,
Copied contents to your clipboard!